SCHEMBL16615320

SCHEMBL16615320

CC(c1c(Cl)ccc(F)c1Cl)N1CCNc2c1c1c(C(=O)Nc3ccc(C(=O)N4CCCC4)cc3)n2-1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 8/20 0.45
MAP4K2 Q12851 1/20 0.45
MAP3K1 Q13233 1/20 0.45
AAK1 Q2M2I8 1/20 0.45
Q6ZSR9 Q6ZSR9 1/20 0.45
MAP4K5 Q9Y4K4 1/20 0.45
MAPT P10636 5/20 0.38
HPGD P15428 4/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
NTRK1 P04629 2/20 0.36
LMNA P02545 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
PKM P14618 1/20 0.36
TP53 P04637 1/20 0.36
ABL1 P00519 1/20 0.35
MST1R Q04912 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16615305 0.91 KMT2A (0.40) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL16615101 0.80 MET (0.46) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL17918726 0.80 MET (0.54) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL20859323 0.80 MET (0.44) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL17969736 0.76 MET (0.43) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL17918857 0.75 MET (0.50) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL16615213 0.73 EPHX2 (0.43) MAPTHPGDALDH1A1MEN1KMT2A
SCHEMBL17918667 0.72 MET (0.46) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL16615299 0.69 POLB (0.41) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL20859457 0.69 MET (0.42) METMAP4K2MAP3K1AAK1Q6ZSR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3050884-A1 NOVEL CHEMICAL COMPOUNDS (VARIANTS) AND THE USE THEREOF TO TREAT ONCOLOGICAL DISEASES Limited Liability Company "National Pharmaceutical (RU) 2016-08-03 EP disclosed
WO-2015047133-A1 NOVEL CHEMICAL COMPOUNDS (VARIANTS) AND THE USE THEREOF TO TREAT ONCOLOGICAL DISEASES ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ОТЕЧЕСТВЕННЫЕ ФАРМАЦЕВТИЧЕСКИЕ ТЕХНОЛОГИИ" 2015-04-02 WO disclosed